Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
Kahn Brothers Group Portfolio 13F
Kahn Brothers Group Holdings Activity
- Portfolio value:
- $700.51M≈ (+$119M≈)
- Previous value:
- $581.04M≈
- # of changes:
- 34
- New positions:
- 0
- Reported for:
- 31 Mar 2014 (Q1)
- Latest filing date:
- 07 May 2014
Kahn Brothers Group has disclosed a total of 34 changes to the portfolio in the (2014 Q1) SEC report(s): increased the number of shares of 25 and decreased the number of shares of 9 position(s).
What stocks did Kahn Brothers Group buy in 2014 Q1?
During 2014 Q1 Kahn Brothers Group has bought 25 securities out of which top 5 purchases (by % change to portfolio) were (NYT) New York Times Company (added shares +11.90%), (PFE) Pfizer Inc (added shares +11.22%), (FLG) Flagstar Financial, Inc (added shares +15.56%), (C) Citigroup Inc (added shares +14.77%) and (ORI) Old Republic International Corp (added shares +10.88%).
In the 2014 Q1 report(s) the following changes have been made to the top investments: (NYT) New York Times Company (added shares +11.90%), (PFE) Pfizer Inc (added shares +11.22%), (MRK) Merck & Company Inc (reduced shares -55.32%), (FLG) Flagstar Financial, Inc (added shares +15.56%) and (C) Citigroup Inc (added shares +14.77%).
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.